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will be retired and replaced by this new version.
The first Medical Toxicology Core Content was developed to assist in the construction of the first examination in 1994. This document consisted of 22 major content areas and was organized, in part, by toxicant classification. Listed under most of these major content areas were exhaustive lists of drugs and toxicants of which a medical toxicologist was expected to have knowledge.
In 2000, the Medical Toxicology Subboard embarked on a major revision of the original Core Content. This undertaking was initiated to update the 1994 Core Content, as well as to improve the framework that conceptualizes the expanding breadth of medical toxicology. In addition, the Subboard wanted to devise a conceptual document that would accommodate future discoveries and changes. A task force of Medical Toxicology Subboard members was convened to develop and draft the revised Core Content, and comments were solicited from stakeholders.
The latest Core Content Task Force was established in 2009 to propose updates to the 2004 Core Content. Development included both extensive discussion by the Medical Toxicology Subboard and the use of a survey of practitioners, which will be reported separately. During the process, input was solicited from the American College of Medical Toxicology, American Academy of Clinical Toxicology, and other interested stakeholders, such as diplomates, medical toxicology fellowship directors, and related organizations.
The Core Content now contains six distinct subject areas: (1) principles of toxicology, (2) toxins and toxicants, (3) clinical assessment, (4) therapeutics, (5) assessment and population health, and (6) analytical and forensic toxicology. The most significant change was the addition of an entire subject area, clinical assessment. Since many clinical encounters begin with a symptom or clinical finding rather than with the knowledge of a specific toxin, the inclusion of this section better aligns the Core Content with clinical practice.
As with previous revisions of the Core Content, the Medical Toxicology Core Content Task Force grappled with what level of detail to include in the document. In this latest revision, the Core Content Task Force revised many of the sections of the previous version, both adding and reducing detail as appropriate. The rationale for adjusting the level of detail provided was the perception that some areas, such as the occupational toxicants, were too specific and needed to be broadened while others, such as drugs of abuse, were not sufficiently inclusive. Given the ongoing introduction of new pharmaceuticals and chemicals, yearly updating of the document to include a definitive list of all toxins and toxicants becomes increasingly unwieldy. A few representative examples are included in many of the drug and toxicant classes for clarity, but the scope of medical toxicology and the examination is not limited to these examples. The Subboard believes it is reasonable that test items can be developed on any agent that could be classified either under a broader category (e.g., drugs that affect the cardiovascular system) or a narrower category (e.g., antihypertensives).
The Core Content is intended to be a living document, in keeping with the ever-evolving practice of medical toxicology. The Medical Toxicology Subboard anticipates regular updates to the Core Content. In order to allow the update process to accurately reflect this evolution, the Subboard welcomes input from its stakeholders. Suggested changes to the Core Content can be addressed to examcontent@abem.org. 
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